Ownership history in Deep Track Capital, LP · 6 quarters on record
This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in ELIEM THERAPEUTICS INC (CLYM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 509,789 | -530,326 | -51.0% | 0.03% | $1.0M | $2.01 |
| 2025 Q2 | UNCHANGED | 1,040,115 | — | 0% | 0.04% | $1.3M | $1.24 |
| 2025 Q1 | UNCHANGED | 1,040,115 | — | 0% | 0.04% | $1.3M | $1.22 |
| 2024 Q4 | REDUCED | 1,040,115 | -1,129,028 | -52.0% | 0.07% | $1.9M | $1.80 |
| 2024 Q3 | REDUCED | 2,169,143 | -1,735,642 | -44.4% | 0.35% | $11.0M | $5.09 |
| 2024 Q2 | INITIATED | 3,904,785 | — | — | 0.83% | $27.8M | — |
As of 2025 Q4 — sorted by position size